{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "%matplotlib inline"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "from __future__ import unicode_literals, print_function, division\n",
    "from io import open\n",
    "import unicodedata\n",
    "import string\n",
    "import re\n",
    "import random\n",
    "import pandas as pd\n",
    "\n",
    "import torch\n",
    "import torch.nn as nn\n",
    "from torch.autograd import Variable\n",
    "from torch import optim\n",
    "import torch.nn.functional as F\n",
    "\n",
    "use_cuda = torch.cuda.is_available()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "SOS_token = 0\n",
    "EOS_token = 1\n",
    "\n",
    "\n",
    "class Lang:\n",
    "    def __init__(self):\n",
    "        self.word2index = {}\n",
    "        self.word2count = {}\n",
    "        self.index2word = {SOS_token: \"SOS\", EOS_token: \"EOS\"}\n",
    "        self.n_words = 2  # Count SOS and EOS\n",
    "\n",
    "    def addSentence(self, sentence):\n",
    "        for word in sentence.split(' '):\n",
    "            self.addWord(word)\n",
    "\n",
    "    def addWord(self, word):\n",
    "        if word not in self.word2index:\n",
    "            self.word2index[word] = self.n_words\n",
    "            self.word2count[word] = 1\n",
    "            self.index2word[self.n_words] = word\n",
    "            self.n_words += 1\n",
    "        else:\n",
    "            self.word2count[word] += 1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Turn a Unicode string to plain ASCII, thanks to\n",
    "# http://stackoverflow.com/a/518232/2809427\n",
    "def unicodeToAscii(s):\n",
    "    return ''.join(\n",
    "        c for c in unicodedata.normalize('NFD', s)\n",
    "        if unicodedata.category(c) != 'Mn'\n",
    "    )\n",
    "\n",
    "# Lowercase, trim, and remove non-letter characters\n",
    "\n",
    "\n",
    "def normalizeString(s):\n",
    "    s = unicodeToAscii(s.lower().strip())\n",
    "    s = re.sub(r\"([.!?])\", r\" \\1\", s)\n",
    "    s = re.sub(r\"[^a-zA-Z.!?]+\", r\" \", s)\n",
    "    return s"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "def loadData(lang, filep = \"./data_train.csv\"):\n",
    "    c = pd.read_csv(filep)\n",
    "    c.fillna({\"title\":'',\"abstract\":''},inplace=True)\n",
    "    c.dropna(inplace=True)\n",
    "    for i,t,a in c[[\"title\",\"abstract\"]].itertuples():\n",
    "        lang.addSentence(t+' '+a)\n",
    "        \n",
    "    return c"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "lang = Lang()\n",
    "train = loadData(lang)\n",
    "test = loadData(lang, \"./data_test.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "train1 = train.sample(frac=0.8)\n",
    "train2 = train.drop(train1.index)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "label2int = {k : i for i,k in enumerate(train.label.unique())}\n",
    "int2label = {v : k for k, v in label2int.items()}"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "6767"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(lang.word2count)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>year</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>89</th>\n",
       "      <td>23235213</td>\n",
       "      <td>2012</td>\n",
       "      <td>Re: Increased survival with enzalutamide in pr...</td>\n",
       "      <td></td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        pmid  year                                              title  \\\n",
       "89  23235213  2012  Re: Increased survival with enzalutamide in pr...   \n",
       "\n",
       "   abstract label  \n",
       "89             E3  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "train.sample()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "class EncoderRNN(nn.Module):\n",
    "    def __init__(self, input_size, hidden_size, n_layers=1):\n",
    "        super(EncoderRNN, self).__init__()\n",
    "        self.n_layers = n_layers\n",
    "        self.hidden_size = hidden_size\n",
    "\n",
    "        self.embedding = nn.Embedding(input_size, hidden_size)\n",
    "        self.gru = nn.GRU(hidden_size, hidden_size)\n",
    "\n",
    "    def forward(self, input, hidden):\n",
    "        embedded = self.embedding(input).view(1, 1, -1)\n",
    "        output = embedded\n",
    "        for i in range(self.n_layers):\n",
    "            output, hidden = self.gru(output, hidden)\n",
    "        return output, hidden\n",
    "\n",
    "    def initHidden(self):\n",
    "        result = Variable(torch.zeros(1, 1, self.hidden_size))\n",
    "        if use_cuda:\n",
    "            return result.cuda()\n",
    "        else:\n",
    "            return result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "class Decoder(nn.Module):\n",
    "    def __init__(self, hidden_size, output_size, n_layers=1):\n",
    "        super(Decoder, self).__init__()\n",
    "        self.hidden_size = hidden_size\n",
    "        self.out = nn.Sequential(*[nn.Linear(hidden_size, hidden_size) for i in range(n_layers-1)],nn.Linear(hidden_size, output_size))\n",
    "        self.softmax = nn.LogSoftmax(dim=0)\n",
    "\n",
    "    def forward(self, hidden):\n",
    "        return self.softmax(self.out(hidden))\n",
    "\n",
    "    def initHidden(self):\n",
    "        result = Variable(torch.zeros(1, 1, self.hidden_size))\n",
    "        if use_cuda:\n",
    "            return result.cuda()\n",
    "        else:\n",
    "            return result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [],
   "source": [
    "def indexesFromSentence(lang, sentence):\n",
    "    return [lang.word2index[word] for word in sentence.split(' ')]\n",
    "\n",
    "\n",
    "def variableFromSentence(lang, sentence):\n",
    "    indexes = indexesFromSentence(lang, sentence)\n",
    "    indexes.append(EOS_token)\n",
    "    indexes.insert(0,SOS_token)\n",
    "    result = Variable(torch.LongTensor(indexes).view(-1, 1))\n",
    "    if use_cuda:\n",
    "        return result.cuda()\n",
    "    else:\n",
    "        return result\n",
    "\n",
    "def variableFromLabel(label):\n",
    "    result = Variable(torch.LongTensor([label2int[label]]))\n",
    "    if use_cuda:\n",
    "        return result.cuda()\n",
    "    else:\n",
    "        return result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [],
   "source": [
    "def trainModel(input_variable, target_variable, encoder, decoder, encoder_optimizer, decoder_optimizer, criterion):\n",
    "    encoder_hidden = encoder.initHidden()\n",
    "\n",
    "    encoder_optimizer.zero_grad()\n",
    "    decoder_optimizer.zero_grad()\n",
    "\n",
    "    input_length = input_variable.size()[0]\n",
    "\n",
    "    loss = 0\n",
    "\n",
    "    for ei in range(input_length):\n",
    "        _, encoder_hidden = encoder(input_variable[ei], encoder_hidden)\n",
    "\n",
    "    decoder_output = decoder(encoder_hidden[0][0]).unsqueeze(0)\n",
    "\n",
    "    loss = criterion(decoder_output, target_variable)\n",
    "    loss.backward()\n",
    "\n",
    "    encoder_optimizer.step()\n",
    "    decoder_optimizer.step()\n",
    "\n",
    "    return loss.data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "import time\n",
    "import math\n",
    "\n",
    "\n",
    "def asMinutes(s):\n",
    "    m = math.floor(s / 60)\n",
    "    s -= m * 60\n",
    "    return '%dm %ds' % (m, s)\n",
    "\n",
    "\n",
    "def timeSince(since, percent):\n",
    "    now = time.time()\n",
    "    s = now - since\n",
    "    es = s / (percent)\n",
    "    rs = es - s\n",
    "    return '%s (- %s)' % (asMinutes(s), asMinutes(rs))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [],
   "source": [
    "def trainIters(train, test, encoder, decoder, n_iters, print_every=1000, plot_every=100, learning_rate=0.01):\n",
    "    start = time.time()\n",
    "    plot_losses = []\n",
    "    print_loss_total = 0  # Reset every print_every\n",
    "    plot_loss_total = 0  # Reset every plot_every\n",
    "    plot_trainScore = []\n",
    "    plot_testScore = []\n",
    "\n",
    "    encoder_optimizer = optim.SGD(encoder.parameters(), lr=learning_rate)\n",
    "    decoder_optimizer = optim.SGD(decoder.parameters(), lr=learning_rate)\n",
    "    criterion = nn.NLLLoss()\n",
    "    scoreTrain, scoreTest = None, None\n",
    "\n",
    "    for iter in range(1, n_iters + 1):\n",
    "        sample = train.sample().iloc[0]\n",
    "        input_variable = variableFromSentence(lang, sample.title)\n",
    "        target_variable = variableFromLabel(sample.label)\n",
    "\n",
    "        loss = trainModel(input_variable, target_variable, encoder,\n",
    "                     decoder, encoder_optimizer, decoder_optimizer, criterion)\n",
    "        print_loss_total += loss\n",
    "        plot_loss_total += loss\n",
    "\n",
    "        if iter % print_every == 0:\n",
    "            print_loss_avg = print_loss_total / print_every\n",
    "            print_loss_total = 0\n",
    "            scoreTrain = score(train, encoder1, decoder1)\n",
    "            scoreTest = score(test, encoder1, decoder1)\n",
    "            print('%s (%d %d%%) %.4f %.2f %.2f' % (timeSince(start, iter / n_iters),\n",
    "                                         iter, iter / n_iters * 100, print_loss_avg, scoreTrain, scoreTest))\n",
    "\n",
    "        if iter % plot_every == 0:\n",
    "            plot_loss_avg = plot_loss_total / plot_every\n",
    "            plot_losses.append(plot_loss_avg)\n",
    "            if scoreTrain :\n",
    "                plot_trainScore.append(scoreTrain)\n",
    "                plot_testScore.append(scoreTest)\n",
    "                \n",
    "            else :\n",
    "                plot_trainScore.append(score(train, encoder, decoder))\n",
    "                plot_testScore.append(score(test, encoder, decoder))\n",
    "            plot_loss_total = 0\n",
    "            scoreTrain, scoreTest = None, None\n",
    "\n",
    "    showPlot(plot_losses)\n",
    "    showPlot(list(zip(plot_trainScore,plot_testScore)))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "import matplotlib.ticker as ticker\n",
    "import numpy as np\n",
    "\n",
    "\n",
    "def showPlot(points):\n",
    "    plt.figure()\n",
    "    fig, ax = plt.subplots()\n",
    "    # this locator puts ticks at regular intervals\n",
    "    loc = ticker.MultipleLocator(base=0.2)\n",
    "    ax.yaxis.set_major_locator(loc)\n",
    "    plt.plot(points)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [],
   "source": [
    "def evaluate(encoder, decoder, sentence):\n",
    "    input_variable = variableFromSentence(lang, sentence)\n",
    "    input_length = input_variable.size()[0]\n",
    "    encoder_hidden = encoder.initHidden()\n",
    "\n",
    "    for ei in range(input_length):\n",
    "        _, encoder_hidden = encoder(input_variable[ei], encoder_hidden)\n",
    "\n",
    "    decoder_output = decoder(encoder_hidden[0][0])\n",
    "\n",
    "    return int2label[decoder_output.data.topk(1)[1][0]]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "def evaluateRandomly(data, encoder, decoder, n=10):\n",
    "    for i in range(n):\n",
    "        sample = data.sample().iloc[0]\n",
    "        inputSentence = sample.title\n",
    "        target = sample.label\n",
    "        print('>', inputSentence)\n",
    "        print('=', target)\n",
    "        output = evaluate(encoder, decoder, inputSentence)\n",
    "        print('<', output)\n",
    "        print('')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [],
   "source": [
    "def score(data, encoder, decoder, n=1000):\n",
    "    cpt = 0\n",
    "    for i in range(n):\n",
    "        sample = data.sample().iloc[0]\n",
    "        inputSentence = sample.title\n",
    "        target = sample.label\n",
    "        output = evaluate(encoder, decoder, inputSentence)\n",
    "        if output == target:\n",
    "            cpt+=1\n",
    "    return cpt/n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1m 2s (- 19m 38s) (100 5%) 1.1427 0.37 0.35\n",
      "1m 52s (- 16m 51s) (200 10%) 1.0498 0.62 0.58\n",
      "2m 43s (- 15m 28s) (300 15%) 0.9684 0.58 0.62\n",
      "3m 41s (- 14m 45s) (400 20%) 0.9557 0.52 0.37\n",
      "4m 33s (- 13m 39s) (500 25%) 0.9217 0.60 0.52\n",
      "5m 23s (- 12m 35s) (600 30%) 0.8518 0.69 0.50\n",
      "6m 15s (- 11m 37s) (700 35%) 0.7798 0.75 0.59\n",
      "7m 9s (- 10m 44s) (800 40%) 0.6808 0.78 0.58\n",
      "8m 1s (- 9m 48s) (900 45%) 0.6635 0.77 0.52\n",
      "8m 52s (- 8m 52s) (1000 50%) 0.5189 0.84 0.57\n",
      "9m 43s (- 7m 57s) (1100 55%) 0.4685 0.88 0.54\n",
      "10m 38s (- 7m 5s) (1200 60%) 0.3259 0.90 0.54\n",
      "11m 31s (- 6m 12s) (1300 65%) 0.3427 0.88 0.42\n",
      "12m 28s (- 5m 20s) (1400 70%) 0.3529 0.91 0.54\n",
      "13m 27s (- 4m 29s) (1500 75%) 0.2702 0.96 0.53\n",
      "14m 29s (- 3m 37s) (1600 80%) 0.2610 0.97 0.50\n",
      "15m 29s (- 2m 44s) (1700 85%) 0.2330 0.95 0.47\n",
      "16m 30s (- 1m 50s) (1800 90%) 0.1617 0.96 0.51\n",
      "17m 23s (- 0m 54s) (1900 95%) 0.0839 0.97 0.52\n",
      "18m 18s (- 0m 0s) (2000 100%) 0.1481 0.98 0.50\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fabf2bcd160>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fabf2bcdba8>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fabec9dd8d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7fabec9f22b0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "hidden_size = 256\n",
    "encoder1 = EncoderRNN(lang.n_words, hidden_size)\n",
    "decoder1 = Decoder(hidden_size,len(int2label))\n",
    "ite = 2000\n",
    "\n",
    "if use_cuda:\n",
    "    encoder1 = encoder1.cuda()\n",
    "    decoder1 = decoder1.cuda()\n",
    "\n",
    "trainIters(train1, train2, encoder1, decoder1, ite, print_every=100, plot_every=50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "> New strategies against prostate cancer--Pt(II)-based chemotherapy.\n",
      "= C2\n",
      "< C2\n",
      "\n",
      "> A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.\n",
      "= A1\n",
      "< A1\n",
      "\n",
      "> The PREVAIL trial of enzalutamide in men with chemotherapy-naïve, metastatic castration-resistant prostate cancer: Post hoc analysis of Korean patients.\n",
      "= E3\n",
      "< E3\n",
      "\n",
      "> Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials.\n",
      "= A1\n",
      "< A1\n",
      "\n",
      "> [Roles of enzalutamide in castrate-resistant prostate cancer].\n",
      "= E3\n",
      "< A1\n",
      "\n",
      "> Cabazitaxel: more than a new taxane for metastatic castrate-resistant prostate cancer?\n",
      "= C2\n",
      "< C2\n",
      "\n",
      "> Docetaxel followed by abiraterone in metastatic castration-resistant prostate cancer: efficacy and predictive parameters in a large single center cohort.\n",
      "= A1\n",
      "< A1\n",
      "\n",
      "> [Treatment of metastatic castration-resistant prostate cancer].\n",
      "= A1\n",
      "< A1\n",
      "\n",
      "> Translating scientific advancement into clinical benefit for castration-resistant prostate cancer patients.\n",
      "= C2\n",
      "< C2\n",
      "\n",
      "> Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate.\n",
      "= A1\n",
      "< A1\n",
      "\n"
     ]
    }
   ],
   "source": [
    "evaluateRandomly(train, encoder1, decoder1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "0.984 0.507\n"
     ]
    }
   ],
   "source": [
    "print(score(train1, encoder1, decoder1),score(train2, encoder1, decoder1))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "labels = [evaluate(encoder1, decoder1, x) for x in test.title]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "test2 = test.assign(label = labels)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>pmid</th>\n",
       "      <th>year</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>label</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>21382150</td>\n",
       "      <td>2011</td>\n",
       "      <td>Current and emerging treatment modalities for ...</td>\n",
       "      <td>Docetaxel-based therapy is established as the ...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>27018069</td>\n",
       "      <td>2016</td>\n",
       "      <td>Enzalutamide in Japanese patients with chemoth...</td>\n",
       "      <td>To evaluate the treatment effects, safety and ...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>24314736</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Corticotherapy in castration-resistant prosta...</td>\n",
       "      <td>Corticosteroids are commonly used in the treat...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>25907622</td>\n",
       "      <td>2015</td>\n",
       "      <td>Clinical outcomes in a contemporary series of ...</td>\n",
       "      <td>The prognosis of younger patients with prostat...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>26633646</td>\n",
       "      <td>2015</td>\n",
       "      <td>Systemic Medical Treatment in Men with Metasta...</td>\n",
       "      <td>The approval or clinical evaluation of several...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>21743442</td>\n",
       "      <td>2011</td>\n",
       "      <td>Prostate cancer: Abiraterone increases overall...</td>\n",
       "      <td></td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>27544577</td>\n",
       "      <td>2016</td>\n",
       "      <td>Reply to Giandomenico Roviello, Daniele Genera...</td>\n",
       "      <td></td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>27474149</td>\n",
       "      <td>2016</td>\n",
       "      <td>Wedelolactone, an anti-inflammatory botanical,...</td>\n",
       "      <td>The c-Myc gene encodes an oncoprotein transcri...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>21076710</td>\n",
       "      <td>2010</td>\n",
       "      <td>Cabazitaxel, a new taxane with favorable prope...</td>\n",
       "      <td>Cabazitaxel is a new taxane characterized by c...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>23436650</td>\n",
       "      <td>2013</td>\n",
       "      <td>The discovery of novel human androgen receptor...</td>\n",
       "      <td>Unraveling the mechanisms involved in castrati...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>22522765</td>\n",
       "      <td>2012</td>\n",
       "      <td>Castration-resistant prostate cancer: systemic...</td>\n",
       "      <td>Prostate cancer is the most common non-cutaneo...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>26829012</td>\n",
       "      <td>2016</td>\n",
       "      <td>Severe neutropenia during cabazitaxel treatmen...</td>\n",
       "      <td>Cabazitaxel significantly improves overall sur...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>23467121</td>\n",
       "      <td>2013</td>\n",
       "      <td>Enzalutamide (Xtandi) for prostate cancer.</td>\n",
       "      <td></td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>26083457</td>\n",
       "      <td>2015</td>\n",
       "      <td>Small-Molecule-Mediated Degradation of the And...</td>\n",
       "      <td>Androgen receptor (AR)-dependent transcription...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>24458472</td>\n",
       "      <td>2014</td>\n",
       "      <td>Clinical variables associated with PSA respons...</td>\n",
       "      <td>Abiraterone acetate (abiraterone) prolongs ove...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>21854708</td>\n",
       "      <td>2011</td>\n",
       "      <td>New treatment options for castrate-resistant p...</td>\n",
       "      <td>Castrate-resistant prostate cancer (CRPC) is t...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>27916295</td>\n",
       "      <td>2016</td>\n",
       "      <td>Association of Biomarkers with Serious Cardiac...</td>\n",
       "      <td>Abiraterone acetate is an effective drug for c...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>26331358</td>\n",
       "      <td>2016</td>\n",
       "      <td>Androgen receptor targeting drugs in castratio...</td>\n",
       "      <td>Reactivated androgen receptor (AR) signaling d...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>25139705</td>\n",
       "      <td>2014</td>\n",
       "      <td>[Pharmacotherapy of solid tumors. New hopes an...</td>\n",
       "      <td>Recent years have seen dramatic changes in the...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>27382012</td>\n",
       "      <td>2016</td>\n",
       "      <td>Hybrid Enzalutamide Derivatives with Histone D...</td>\n",
       "      <td>Histone deacetylase inhibitors (HDACIs) can di...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>21577234</td>\n",
       "      <td>2011</td>\n",
       "      <td>Evolving standards in the treatment of docetax...</td>\n",
       "      <td>The management of men with metastatic castrati...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>25018038</td>\n",
       "      <td>2014</td>\n",
       "      <td>Efficacy of enzalutamide following abiraterone...</td>\n",
       "      <td>The activity of enzalutamide after prior treat...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>26509262</td>\n",
       "      <td>2015</td>\n",
       "      <td>Divergent Androgen Receptor and Beta-Catenin S...</td>\n",
       "      <td>Despite decades of effort to develop effective...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>22078584</td>\n",
       "      <td>2011</td>\n",
       "      <td>Re: Abiraterone and increased survival in meta...</td>\n",
       "      <td></td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>26044568</td>\n",
       "      <td>2016</td>\n",
       "      <td>The Epidemiological, Mechanistic and Potential...</td>\n",
       "      <td>The androgen receptor (AR) is a ligand-inducib...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>23042445</td>\n",
       "      <td>2012</td>\n",
       "      <td>Enzalutamide (formerly MDV3100) as a new thera...</td>\n",
       "      <td>Enzalutamide marks the latest addition to the ...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>26311471</td>\n",
       "      <td>2015</td>\n",
       "      <td>Novel agents for castration-resistant prostate...</td>\n",
       "      <td>Androgen deprivation therapy is the initial tr...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>26454199</td>\n",
       "      <td>2015</td>\n",
       "      <td>Lack of interaction between enzalutamide and w...</td>\n",
       "      <td>Enzalutamide is an androgen receptor antagonis...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>24276853</td>\n",
       "      <td>2013</td>\n",
       "      <td>Evolution of the treatment paradigm for patien...</td>\n",
       "      <td>As recently as 2004, treatment options for men...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>27515296</td>\n",
       "      <td>2016</td>\n",
       "      <td>Uncontrolled diabetes predicts poor response t...</td>\n",
       "      <td>Metabolic abnormalities including hyperglycemi...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>30</th>\n",
       "      <td>21680545</td>\n",
       "      <td>2011</td>\n",
       "      <td>Overcoming chemotherapy resistance in prostate...</td>\n",
       "      <td>Although treatment for prostate cancer has imp...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>31</th>\n",
       "      <td>25420520</td>\n",
       "      <td>2014</td>\n",
       "      <td>ERG induces taxane resistance in castration-re...</td>\n",
       "      <td>Taxanes are the only chemotherapies used to tr...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>32</th>\n",
       "      <td>27572899</td>\n",
       "      <td>2016</td>\n",
       "      <td>Cabazitaxel-induced autophagy via the PI3K/Akt...</td>\n",
       "      <td>Cabazitaxel has been used to treat castration-...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>33</th>\n",
       "      <td>24314737</td>\n",
       "      <td>2013</td>\n",
       "      <td>[Prostate cancer and new hormonal treatments: ...</td>\n",
       "      <td>New drugs have recently been developed, throug...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>34</th>\n",
       "      <td>25927139</td>\n",
       "      <td>2015</td>\n",
       "      <td>Inhibition of Plk1 represses androgen signalin...</td>\n",
       "      <td>Prostate cancer (PCa) is the second leading ca...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>35</th>\n",
       "      <td>27822685</td>\n",
       "      <td>2016</td>\n",
       "      <td>Sequencing Treatment for Castration-Resistant ...</td>\n",
       "      <td>Prostate cancer is the most common non-cutaneo...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>36</th>\n",
       "      <td>25856659</td>\n",
       "      <td>2015</td>\n",
       "      <td>Clinical perspectives: practical insights from...</td>\n",
       "      <td>Prostate cancer, and in particular the managem...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>37</th>\n",
       "      <td>27202160</td>\n",
       "      <td>2016</td>\n",
       "      <td>Comparison of Mean Overall Survival (OS) and R...</td>\n",
       "      <td></td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>38</th>\n",
       "      <td>25848909</td>\n",
       "      <td>2015</td>\n",
       "      <td>Treatment patterns and clinical effectiveness ...</td>\n",
       "      <td>Treatment for metastatic castrate-resistant pr...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>39</th>\n",
       "      <td>24741024</td>\n",
       "      <td>2014</td>\n",
       "      <td>Chromogranin A predicts outcome in prostate ca...</td>\n",
       "      <td>In this retrospective study, we evaluated the ...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>40</th>\n",
       "      <td>28191869</td>\n",
       "      <td>2017</td>\n",
       "      <td>Aberrant corticosteroid metabolism in tumor ce...</td>\n",
       "      <td>Prostate cancer is driven by androgen stimulat...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>41</th>\n",
       "      <td>28183253</td>\n",
       "      <td>2017</td>\n",
       "      <td>Optimal Management of Prostate Cancer Based on...</td>\n",
       "      <td>Prostate cancer is the most common malignancy ...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>42</th>\n",
       "      <td>26585210</td>\n",
       "      <td>2016</td>\n",
       "      <td>Addition of PSMA ADC to enzalutamide therapy s...</td>\n",
       "      <td>Despite multiple new therapies available to pa...</td>\n",
       "      <td>A1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>27618249</td>\n",
       "      <td>2016</td>\n",
       "      <td>Quality of life and pain relief in men with me...</td>\n",
       "      <td>To examine health-related quality of life in m...</td>\n",
       "      <td>C2</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>44</th>\n",
       "      <td>26992199</td>\n",
       "      <td>2016</td>\n",
       "      <td>Multifaceted and personalized therapy of advan...</td>\n",
       "      <td>A number of molecular and genomic biomarkers t...</td>\n",
       "      <td>E3</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        pmid  year                                              title  \\\n",
       "0   21382150  2011  Current and emerging treatment modalities for ...   \n",
       "1   27018069  2016  Enzalutamide in Japanese patients with chemoth...   \n",
       "2   24314736  2013  [Corticotherapy in castration-resistant prosta...   \n",
       "3   25907622  2015  Clinical outcomes in a contemporary series of ...   \n",
       "4   26633646  2015  Systemic Medical Treatment in Men with Metasta...   \n",
       "5   21743442  2011  Prostate cancer: Abiraterone increases overall...   \n",
       "6   27544577  2016  Reply to Giandomenico Roviello, Daniele Genera...   \n",
       "7   27474149  2016  Wedelolactone, an anti-inflammatory botanical,...   \n",
       "8   21076710  2010  Cabazitaxel, a new taxane with favorable prope...   \n",
       "9   23436650  2013  The discovery of novel human androgen receptor...   \n",
       "10  22522765  2012  Castration-resistant prostate cancer: systemic...   \n",
       "11  26829012  2016  Severe neutropenia during cabazitaxel treatmen...   \n",
       "12  23467121  2013         Enzalutamide (Xtandi) for prostate cancer.   \n",
       "13  26083457  2015  Small-Molecule-Mediated Degradation of the And...   \n",
       "14  24458472  2014  Clinical variables associated with PSA respons...   \n",
       "15  21854708  2011  New treatment options for castrate-resistant p...   \n",
       "16  27916295  2016  Association of Biomarkers with Serious Cardiac...   \n",
       "17  26331358  2016  Androgen receptor targeting drugs in castratio...   \n",
       "18  25139705  2014  [Pharmacotherapy of solid tumors. New hopes an...   \n",
       "19  27382012  2016  Hybrid Enzalutamide Derivatives with Histone D...   \n",
       "20  21577234  2011  Evolving standards in the treatment of docetax...   \n",
       "21  25018038  2014  Efficacy of enzalutamide following abiraterone...   \n",
       "22  26509262  2015  Divergent Androgen Receptor and Beta-Catenin S...   \n",
       "23  22078584  2011  Re: Abiraterone and increased survival in meta...   \n",
       "24  26044568  2016  The Epidemiological, Mechanistic and Potential...   \n",
       "25  23042445  2012  Enzalutamide (formerly MDV3100) as a new thera...   \n",
       "26  26311471  2015  Novel agents for castration-resistant prostate...   \n",
       "27  26454199  2015  Lack of interaction between enzalutamide and w...   \n",
       "28  24276853  2013  Evolution of the treatment paradigm for patien...   \n",
       "29  27515296  2016  Uncontrolled diabetes predicts poor response t...   \n",
       "30  21680545  2011  Overcoming chemotherapy resistance in prostate...   \n",
       "31  25420520  2014  ERG induces taxane resistance in castration-re...   \n",
       "32  27572899  2016  Cabazitaxel-induced autophagy via the PI3K/Akt...   \n",
       "33  24314737  2013  [Prostate cancer and new hormonal treatments: ...   \n",
       "34  25927139  2015  Inhibition of Plk1 represses androgen signalin...   \n",
       "35  27822685  2016  Sequencing Treatment for Castration-Resistant ...   \n",
       "36  25856659  2015  Clinical perspectives: practical insights from...   \n",
       "37  27202160  2016  Comparison of Mean Overall Survival (OS) and R...   \n",
       "38  25848909  2015  Treatment patterns and clinical effectiveness ...   \n",
       "39  24741024  2014  Chromogranin A predicts outcome in prostate ca...   \n",
       "40  28191869  2017  Aberrant corticosteroid metabolism in tumor ce...   \n",
       "41  28183253  2017  Optimal Management of Prostate Cancer Based on...   \n",
       "42  26585210  2016  Addition of PSMA ADC to enzalutamide therapy s...   \n",
       "43  27618249  2016  Quality of life and pain relief in men with me...   \n",
       "44  26992199  2016  Multifaceted and personalized therapy of advan...   \n",
       "\n",
       "                                             abstract label  \n",
       "0   Docetaxel-based therapy is established as the ...    C2  \n",
       "1   To evaluate the treatment effects, safety and ...    A1  \n",
       "2   Corticosteroids are commonly used in the treat...    A1  \n",
       "3   The prognosis of younger patients with prostat...    E3  \n",
       "4   The approval or clinical evaluation of several...    C2  \n",
       "5                                                        E3  \n",
       "6                                                        A1  \n",
       "7   The c-Myc gene encodes an oncoprotein transcri...    E3  \n",
       "8   Cabazitaxel is a new taxane characterized by c...    E3  \n",
       "9   Unraveling the mechanisms involved in castrati...    A1  \n",
       "10  Prostate cancer is the most common non-cutaneo...    C2  \n",
       "11  Cabazitaxel significantly improves overall sur...    A1  \n",
       "12                                                       A1  \n",
       "13  Androgen receptor (AR)-dependent transcription...    A1  \n",
       "14  Abiraterone acetate (abiraterone) prolongs ove...    A1  \n",
       "15  Castrate-resistant prostate cancer (CRPC) is t...    A1  \n",
       "16  Abiraterone acetate is an effective drug for c...    E3  \n",
       "17  Reactivated androgen receptor (AR) signaling d...    C2  \n",
       "18  Recent years have seen dramatic changes in the...    A1  \n",
       "19  Histone deacetylase inhibitors (HDACIs) can di...    C2  \n",
       "20  The management of men with metastatic castrati...    C2  \n",
       "21  The activity of enzalutamide after prior treat...    C2  \n",
       "22  Despite decades of effort to develop effective...    C2  \n",
       "23                                                       A1  \n",
       "24  The androgen receptor (AR) is a ligand-inducib...    A1  \n",
       "25  Enzalutamide marks the latest addition to the ...    C2  \n",
       "26  Androgen deprivation therapy is the initial tr...    C2  \n",
       "27  Enzalutamide is an androgen receptor antagonis...    C2  \n",
       "28  As recently as 2004, treatment options for men...    C2  \n",
       "29  Metabolic abnormalities including hyperglycemi...    C2  \n",
       "30  Although treatment for prostate cancer has imp...    C2  \n",
       "31  Taxanes are the only chemotherapies used to tr...    C2  \n",
       "32  Cabazitaxel has been used to treat castration-...    C2  \n",
       "33  New drugs have recently been developed, throug...    E3  \n",
       "34  Prostate cancer (PCa) is the second leading ca...    A1  \n",
       "35  Prostate cancer is the most common non-cutaneo...    C2  \n",
       "36  Prostate cancer, and in particular the managem...    A1  \n",
       "37                                                       C2  \n",
       "38  Treatment for metastatic castrate-resistant pr...    A1  \n",
       "39  In this retrospective study, we evaluated the ...    A1  \n",
       "40  Prostate cancer is driven by androgen stimulat...    E3  \n",
       "41  Prostate cancer is the most common malignancy ...    E3  \n",
       "42  Despite multiple new therapies available to pa...    A1  \n",
       "43  To examine health-related quality of life in m...    C2  \n",
       "44  A number of molecular and genomic biomarkers t...    E3  "
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "test2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [],
   "source": [
    "test2.to_csv(\"./data_test_infer.csv\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.6.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
